The first biosimilar epoetin: but how similar is it?
Schellekens
Huub
H
Departments of Pharmaceutical and Innovation Sciences, Utrecht University, P.O. Box 80.082, 3508 TB Utrecht, The Netherlands. h.schellekens@uu.nl
D000740:Anemia / Q000188:drug therapy*; D001688:Biological Products / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005062:European Union; D006397:Hematinics / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins; D013810:Therapeutic Equivalency
D001688:Biological Products; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa